Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The hemagglutinin (HA) stalk domain is a highly conserved region of the influenza A virus HA protein, crucial for mediating membrane fusion during viral entry. It is the target of broadly neutralizing antibodies and is a focus for universal influenza vaccine development. It consists of parts of both the HA1 and HA2 subunits.
Inhibition of membrane fusion; antibody-dependent cell-mediated cytotoxicity (ADCC); antibody-dependent cell-mediated phagocytosis (ADCP); complement-dependent cytotoxicity (CDC)
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Hemagglutinin Stalk Domain (HA stalk).